K2 Principal Fund, L.P. Nevro Corp Put Options Transaction History

K2 Principal Fund, L.P.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$14.18 - $22.31 $530,332 - $834,394	37,400 New	37,400 $804,000
Q4 2022 Feb 10, 2023	SELL	$36.43 - $49.4 $1.31 Million - $1.78 Million	-36,000 Reduced 56.87%	27,300 $1.08 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $69,122 - $90,151	1,700 Added 2.76%	63,300 $2.95 Million
Q2 2022 Aug 12, 2022	SELL	$40.85 - $77.67 $2.17 Million - $4.13 Million	-53,200 Reduced 46.34%	61,600 $2.7 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $6.4 Million - $9.83 Million	106,800 Added 1335.0%	114,800 $8.3 Million
Q4 2021 Feb 11, 2022	BUY	$81.07 - $121.29 $648,560 - $970,320	8,000 New	8,000 $649,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.